MRE-269
MRE-269, also known as ACT-333679, is a long-acting and highly selective prostacyclin receptor agonist. MRE-269, the active form or metabolite of Selexipag (NS-304), is much more selective for the IP receptor than are the prostacyclin analogs beraprost and iloprost, which also have high affinity for the EP (3) receptor.
Product Specifications
CAS Number
475085-57-5
Product Name Alternative
MRE-269 | MRE269 | MRE 269 | ACT-333679
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 50 mg/mL. 119.18 mM; H2O : < 0.1 mg/mL
Smiles
CC1CCC2 (CCC3 (C (=CCC4C3 (CCC5C4 (CCC (=O) C5 (C) C) C) C) C2C1C) C) C (=O) O
Molecular Formula
C25H29N3O3
Molecular Weight
419.52
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2- (4- ((5,6-diphenylpyrazin-2-yl) (isopropyl) amino) butoxy) acetic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15301556 1 Vial
Lentiviral mouse Plekha1 shRNA (UAS) - Lentiviral mouse Plekha1 shRNA (UAS) (25)
Sign In for Pricing
View Details